Skip to main content

uniQure N.V. (QURE) Stock

uniQure N.V. Stock Details, Movements and Public Alerts

Stock Details

uniQure N.V. (QURE), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $60.18. Over the past 52 weeks, it has ranged between $4.45 and $59.83. This places the current price at 100.6% of its 52-week high and 1252.4% above its 52-week low. The 14-day Relative Strength Index (RSI) stands at 93.35, suggesting overbought conditions. The stock is currently trading above its 50-day moving average of $18.30 by 228.85%. Similarly, it is above its 200-day moving average of $15.14 by 297.49%. The MACD histogram is 4.94, indicating bullish momentum (MACD Line: 8.54, Signal Line: 3.60). There is currently 1 active alert set for QURE by users.

Market Cap

$2.61B

52-Week High

$59.83

0.58% from high

52-Week Low

$4.45

+1252.36% from low

Avg Daily Volume

2,317,117

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

27.93

PEG Ratio

0.00

Potentially undervalued

Price to Book

2.83

EV/EBITDA

0.99

EPS (TTM)

-$3.90

Price to Sales

181.78

Beta

0.13

Less volatile than market

How is QURE valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is QURE's risk profile compared to the market?
With a beta of 0.13, uniQure N.V. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 2.83 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-791.00%

Return on Equity

-427.50%

Return on Assets

-15.40%

Revenue Growth (YoY)

-52.70%

Earnings Growth (YoY)

-18.20%

How profitable and efficient is QURE's business model?
0 The operating margin of -791.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -427.50% and ROA at -15.40%, the company achieves moderate returns on invested capital.
What are QURE's recent growth trends?
uniQure N.V.'s revenue declined by 52.70% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings decreased by 18.20% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Shares Outstanding

54.87M

Book Value/Share

-$0.07

Asset Type

Common Stock

What is QURE's market capitalization and position?
uniQure N.V. has a market capitalization of $2.61B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 54.87M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does QURE's price compare to its book value?
uniQure N.V.'s book value per share is -$0.07, while the current stock price is $60.18, resulting in a price-to-book (P/B) ratio of -824.38. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$54.83

8.89% downside potential

Analyst Recommendations

Strong Buy

2

Buy

10

Hold

1

Sell

0

Strong Sell

0

How reliable are analyst predictions for QURE?
13 analysts cover QURE with 92% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $54.83 implies -8.9% downside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on QURE?
Current analyst recommendations:2 Strong Buy, 10 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 26, 2025, 03:14 AM

Earnings Dates

Upcoming Earnings

Q3

Oct 29, 2025

Est. EPS: $-0.93

In 29 days

Recent Earnings History

DateQuarterEstimated EPSActual EPSSurprise
Jul 29, 2025Q2$-0.89$-0.69+22.5%
May 9, 2025Q1$-0.89$-0.73+17.9%
Feb 27, 2025Q4$-0.52$-1.44-178.8%
Nov 5, 2024Q3$-1.02$-0.91+10.8%
Aug 1, 2024Q2$-1.25$-1.16+7.2%
May 7, 2024Q1$-1.28$-1.36-6.3%
Feb 28, 2024Q4$-1.46$-1.53-4.8%
Nov 7, 2023Q3$-0.85$-1.88-121.2%

Technical Indicators

RSI (14-day)

93.35

Overbought

50-Day Moving Average

$18.30

228.85% above MA-50

200-Day Moving Average

$15.14

297.49% above MA-200

MACD Line

8.54

MACD Signal

3.60

MACD Histogram

4.94

Bullish

What does QURE's RSI value tell investors?
The RSI (Relative Strength Index) for QURE is currently 93.35, indicating the stock is in overbought territory (above 70). This suggests strong recent buying pressure that may be unsustainable. While overbought conditions can persist in strong trends, traders often watch for RSI divergences or a drop below 70 as potential sell signals. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret QURE's MACD and moving average crossovers?
MACD analysis shows the MACD line at 8.54 above the signal line at 3.60, with histogram at 4.94. This bullish crossover suggests upward momentum is building. The wide histogram confirms strong momentum. The 50-day MA ($18.30) is above the 200-day MA ($15.14), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Sep 30, 2025, 08:12 AM

Active Alerts

Alert Condition
RSI Threshold Cross
Threshold
70
Created
Sep 26, 2025, 03:20 AM

Stay Ahead of the Market with uniQure N.V. Alerts

Set up price alerts for uniQure N.V. and get notified instantly when the price hits your target. Never miss an important price movement again.